Work

Clinical and Molecular Characterization of Newly Diagnosed IDH/TP53 Co-Mutated AML and Impact of Genomically Sensitive Treatment Strategies

Year: 2022

Type: article

Study design: Observational Study

Source: Blood

DOI: 10.1182/blood-2022-169778

Authors: Sangeetha Venugopal, Sanam Loghavi, Mark Routbort, Fatima Zahra Jelloul, Rashmi Kanagal-Shamanna, Sherry A. Pierce, Ghayas C. Issa, Hussein A Abbas, Koji Sasaki, Koichi Takahashi, Naval Daver, Farhad Ravandi, Hagop Kantarjian, Courtney D. DiNardo

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4310107100

FWCI:

Cites:

Cited by:

Related to: 10